Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression.
Tumor metastases suppressor protein KAI1/CD82 is capable of blocking the tumor metastases without affecting the primary tumor formation, and its expression is significantly down-regulated in many types of human cancers. However, the exact molecular mechanism of the suppressor function of KAI1 remains elusive. Evidence from our laboratory supports a model in which tumor cells dislodge from the primary tumor and intravasate into the blood or lymphatic vessels followed by attachment to the endothelial cell surface whereby KAI1 interacts with the Duffy antigen receptor for chemokines (DARC) protein. This interaction transmits a senescent signal to cancer cells expressing KAI1, whereas cells that lost KAI1 expression can proliferate, potentially giving rise to metastases. Our model of the mechanism of action of KAI1 shows that metastasis suppressor activity can be dependent on interaction with host tissue and explains how KAI1 suppresses metastasis without affecting primary tumor formation. Taken together, in vitro and in vivo studies identify the KAI1-DARC interaction as a potential target for cancer therapy.
Iiizumi
Megumi
M
Department of Medical Microbiology and Immunology, Southern Illinois University School of Medicine, 801 North Rutledge Street, Springfield, IL 62794, USA.
Bandyopadhyay
Sucharita
S
Watabe
Kounosuke
K
D004375:Duffy Blood-Group System / Q000378:metabolism*; D042783:Endothelial Cells / Q000378:metabolism; D006801:Humans; D051861:Kangai-1 Protein / Q000378:metabolism*; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology; D011956:Receptors, Cell Surface / Q000378:metabolism*
C473745:ACKR1 protein, human; C497688:CD82 protein, human; D004375:Duffy Blood-Group System; D051861:Kangai-1 Protein; D011956:Receptors, Cell Surface